Cargando…

Prognosis impact of clinical characteristics in patients with inoperable esophageal squamous cell carcinoma

BACKGROUND: Patients with inoperable esophageal squamous cell carcinoma (ESCC) were not homogeneous and their outcomes were widely divergent. There was a lack of identified clinical factors related to prognosis; and there were no previous studies constructing prognosis score to predict survival and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Ying, Jia, Jun, Sun, Zhiwei, Du, Feng, Yu, Jing, Liu, Chuanling, Xiao, Yanjie, Zhang, Xiaodong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546576/ https://www.ncbi.nlm.nih.gov/pubmed/28783764 http://dx.doi.org/10.1371/journal.pone.0182660

Ejemplares similares

Association Between Multiple Lines of Active Therapy and Prognosis in Esophageal Squamous Cell Carcinoma
por: Yang, Ying, et al.
Publicado: (2020)

Phase 1 dose-escalation study of apatinib and irinotecan in esophageal squamous cell carcinoma patients
por: Jia, Jun, et al.
Publicado: (2021)

Integrated bioinformatics analysis to identify key genes related to the prognosis of esophageal squamous cell carcinoma
por: Yang, Ying, et al.
Publicado: (2021)

Clinical significance of serum tumor markers for advanced gastric cancer with the first-line chemotherapy
por: Sun, Zhiwei, et al.
Publicado: (2019)

A phase II study of concurrent chemoradiotherapy and erlotinib for inoperable esophageal squamous cell carcinoma
por: Zhao, Chuanhua, et al.
Publicado: (2016)

Endoscopic debulking resection with additive chemoradiotherapy: Optimal management of advanced inoperable esophageal squamous cell carcinoma
por: Ren, Li-Hua, et al.
Publicado: (2022)

Is There a Benefit in Receiving Concurrent Chemoradiotherapy for Elderly Patients with Inoperable Thoracic Esophageal Squamous Cell Carcinoma?
por: Zhang, Peng, et al.
Publicado: (2014)

Safety and efficacy of radiation and chemoradiation in patients over 70 years old with inoperable esophageal squamous cell carcinoma
por: XU, HONG-YU, et al.
Publicado: (2014)

Brain Metastases from Esophageal Squamous Cell Carcinoma: Clinical Characteristics and Prognosis
por: Xiao, Linlin, et al.
Publicado: (2021)

A Retrospective Comparison of Taxane and Fluorouracil-based Chemoradiotherapy in Patients with Inoperable Esophageal Squamous Cell Carcinoma
por: Sun, Xiaojiang, et al.
Publicado: (2016)

Corrigendum: Brain Metastases from Esophageal Squamous Cell Carcinoma: Clinical Characteristics and Prognosis
por: Xiao, Linlin, et al.
Publicado: (2022)

Clinicopathological characteristics and postoperative prognosis of patients with nuclear pedigree of esophageal squamous cell carcinoma
por: Wei, Meng Xia, et al.
Publicado: (2023)

Comparative study of self-expanding metal stent and intraluminal radioactive stent for inoperable esophageal squamous cell carcinoma
por: Tian, Dong, et al.
Publicado: (2016)

Endostatin and Oxaliplatin‐Based Chemoradiotherapy for Inoperable Esophageal Squamous Cell Carcinoma: Results of a Phase II Study
por: Li, Wenxin, et al.
Publicado: (2019)

Sequential boost of intensity‐modulated radiotherapy with chemotherapy for inoperable esophageal squamous cell carcinoma: A prospective phase II study
por: Fan, Xing‐Wen, et al.
Publicado: (2020)

The Modified Glasgow Prognostic Score Is an Independent Prognostic Factor in Patients with Inoperable Thoracic Esophageal Squamous Cell Carcinoma Undergoing Chemoradiotherapy
por: Zhang, Peng, et al.
Publicado: (2014)

Lymphopenia Predicts Poor Prognosis in Patients With Esophageal Squamous Cell Carcinoma
por: Feng, Ji-Feng, et al.
Publicado: (2014)

Individualized treatment decision model for inoperable elderly esophageal squamous cell carcinoma based on multi-modal data fusion
por: Huang, Yong, et al.
Publicado: (2023)

Acute toxicity of definitive chemoradiation in patients with inoperable or irresectable esophageal carcinoma
por: Haj Mohammad, Nadia, et al.
Publicado: (2014)

Clinicopathological characteristics and prognosis of brain metastases in elderly patients with esophageal carcinoma
por: Wang, Yi, et al.
Publicado: (2021)

Development and Validation of an Individualized Nomogram for Predicting Survival in Patients with Esophageal Carcinoma after Resection
por: Du, Feng, et al.
Publicado: (2020)

Esophageal squamous cell carcinoma and prognosis in Taiwan
por: Cheng, Ya‐Fu, et al.
Publicado: (2018)

A Panel of Overexpressed Proteins for Prognosis in Esophageal Squamous Cell Carcinoma
por: Shang, Li, et al.
Publicado: (2014)

The epithelial-mesenchymal transition phenotype of metastatic lymph nodes impacts the prognosis of esophageal squamous cell carcinoma patients
por: Wen, Jing, et al.
Publicado: (2016)

A novel 125I seeds fixed on gastric tube for treatment of inoperable esophageal carcinoma: A case report
por: Jin, Jing, et al.
Publicado: (2021)

Nimotuzumab Plus Paclitaxel and Cisplatin as a 1(st)-Line Treatment for Esophageal Cancer: Long Term Follow-up of a Phase II Study
por: Zhang, Xiaodong, et al.
Publicado: (2019)

DEPTOR suppresses the progression of esophageal squamous cell carcinoma and predicts poor prognosis
por: Ji, Yan-Mei, et al.
Publicado: (2016)

Characteristics and interplay of esophageal microbiota in esophageal squamous cell carcinoma
por: Lin, Zheng, et al.
Publicado: (2022)

Nimotuzumab in the Treatment of Inoperable Esophageal Tumors of Epithelial Origin
por: González Fernández, Sandra, et al.
Publicado: (2022)

MXD1 is a Potential Prognostic Biomarker and Correlated With Specific Molecular Change and Tumor Microenvironment Feature in Esophageal Squamous Cell Carcinoma
por: Du, Feng, et al.
Publicado: (2021)

Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinoma
por: Guo, Jing, et al.
Publicado: (2022)

RAP80 is an independent prognosis biomarker for the outcome of patients with esophageal squamous cell carcinoma
por: Yang, Qingyuan, et al.
Publicado: (2018)

Hypertension predicts a poor prognosis in patients with esophageal squamous cell carcinoma
por: Liang, Jie, et al.
Publicado: (2018)

Interactive Effects of PD-L1 Expression in Tumor and Immune Cells on Prognosis of Esophageal Squamous Cell Carcinoma: A One-Center Retrospective Cohort Study
por: Shi, Feng, et al.
Publicado: (2020)

ILK predicts the efficacy of chemoradiotherapy and the prognosis of patients with esophageal squamous cell carcinoma
por: Ma, Xiao-Li, et al.
Publicado: (2019)

Treatment of esophageal cancer in inoperable elderly patients: our experience
por: Frazzetta, F, et al.
Publicado: (2009)

Identification and validation of an eight-lncRNA signature that predicts prognosis in patients with esophageal squamous cell carcinoma
por: Zhang, Jinfeng, et al.
Publicado: (2022)

UBE2T Contributes to the Prognosis of Esophageal Squamous Cell Carcinoma
por: Wang, Xiaoyuan, et al.
Publicado: (2021)

Serum Metabolomic Profiling Reveals Biomarkers for Early Detection and Prognosis of Esophageal Squamous Cell Carcinoma
por: Wang, Pan Pan, et al.
Publicado: (2022)

Plasma fibrinogen levels are correlated with postoperative distant metastasis and prognosis in esophageal squamous cell carcinoma
por: Zhang, Danhong, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tjf6htc95vmi6kjgaog4ka95f4